Scandal-Hit Kobayashi Pharma Withdraws 2024 Earnings Forecasts
Kobayashi Pharmaceutical Co. on Friday withdrew its consolidated earnings forecasts for the business year to December 2024, citing difficulties in assessing the impact of a scandal involving its supplement products containing “beni koji” red fermented rice.




